Immunitybio Inc (IBRX)

R&D Expense Growth

9.33%

Fiscal year · Period ending:

IBRX logo

IBRX R&D Expense Growth

Latest reported9.33%
IBRX FY R&D Growth (YoY) (0.00% → 9.33%)
High-resolution chart · PNG

IBRX r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunitybio Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
9.325%
-18.1705%
-6.3603%
26.6338%
40.4646%
185.3779%
-8.4859%
34.2903%
49.8456%
132.1672%
616.8652%
257.6233%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.